The efficiency of public spending in Brazil on HIV/AIDS: An analysis from 2012 to 2022
DOI:
https://doi.org/10.31501/rbee.v23i2.14832Abstract
The objective of this study is to evaluate the efficiency of HIV/AIDS public expenditures in Brazil between 2012 and 2022. To achieve this objective, it was necessary to use the non-parametric technique of Data Envelopment Analysis (DEA). The variables used were the total expenditure on HIV/AIDS as input factors, and the outcome variables were the number of AIDS cases. The DEA model, which consists of Variable Returns to Scale (BCC) result oriented, is most often used in the analysis of public expenditure, since it makes no sense to cut healthcare expenditure. The results obtained with the evolution of expenses show a continuous and growing increase in the volumes used, with 73% of expenses only on ARV medicines. Regarding efficiency, the results show that out of the ten years analyzed, half were efficient, while the other half have shown inefficiency in the use of public resources in the fight against HIV/AIDS.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Brazilian Journal of Business Economics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The submission of a manuscript authorizes its publication by the Brazilian Journal of Business Economics/Revista Brasileira de Economia de Empresas and implies that it refers to original work, which is not currently submitted to any other journal. It is forbidden any reproduction, partial or total, by any other media, either press or digital, of the published papers. In this case, previous and necessary authorization must be requested. In case it is obtained, one must include a formal acknowledgement to the BJBE/RBEE, which is the first publisher of the paper. The BJBE/RBEE does not pay any copyright to the authors of published papers.
Copyright and Licensing
The copyrighter of the BJBE/RBEE is the Editora Universa of the Universidade Católica de Brasília.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Submitting an article authorizes its publication and implies a commitment that the same material will not be submitted to another journal.
The journal does not pay royalties to the authors of published articles.
